1 Participant‐reported scar improvement (1 month) |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
2 Investigator‐assessed scar improvement (1 month) |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
3 Patient satisfaction |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
4 Participant‐reported adverse events (< 4 weeks) |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
5 Investigator‐assessed adverse events (1 month) |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
5.1 Hyperpigmentation |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
6 Post‐procedure down time |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |